
Bodal Chemicals Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 2
Fundraise
N/A
Order
No
Capex
Yes
1 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- Demand is currently subdued, with slow performance in key sectors like textile, leather, and paper.
- Industry expects weakness to continue in the short term, with a gradual recovery anticipated from the second half of FY24.
- Dye intermediates prices (e.g., H-Acid and Vinyl Sulphone) are low, but a level playing field with China is established, reducing dumping concerns.
- Production volumes for dye stuffs have increased quarter-on-quarter, but sales volumes remain affected by subdued demand.
- Chlor-Alkali business expects meaningful contribution in coming years due to technology upgradation and healthy demand from FMCG, textile, and paper industries.
- New benzene derivatives capacity (63,000 MT) expected to start trial runs by Q3 FY24, aiding diversification and growth.
- Internal measures such as plant optimization and overhead cost reduction will improve profitability.
- Overall, growth momentum in India is strong, and the Company is optimistic about demand recovery from the second half of the year.
See what Bodal Chemicals management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The transcript does not mention any current or future plans for fundraising through debt or equity.
- No specific discussions or indications about raising capital via loans, bonds, or issuing new shares were made during the Q1 FY24 earnings call.
- The management focused on operational performance, cost-saving measures, site rationalization, and market conditions but did not address fundraising activities.
- The Company is working on improving profitability internally and awaiting incentives but has not indicated any need for external fundraising at present.
See what Bodal Chemicals management said on order book — free account, 30 seconds.
Capex plans
Yes- Bodal Chemicals is installing a capacity of 63,000 metric tons per annum for benzene derivatives, progressing well with the Saykha Greenfield project expected to start trial runs from Q3 FY24.
- The company is working on upgrading technology and diversifying from core dye stuff and dye intermediate businesses to specialty chemical products like benzene derivatives.
- Once the new business site stabilizes with decent demand visibility, the company plans to restart its Sulphuric Acid project.
- Internally, Bodal is considering closing or stopping production at some manufacturing sites with high overhead costs and low margins to reduce expenses by up to Rs. 2 crore per month.
Track Bodal Chemicals — get its next earnings analysis in your feed
How does Bodal Chemicals rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Bodal Chemicals rank in Chemicals & Petrochemicals?
Compare Bodal Chemicals against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…